Australia's CSL Ltd said it's evaluating whether its drugs used in surgery would be exempted from 125% tariffs China imposed ...

Policy uncertainties are impacting biopharma dealmaking from continent to continent, with companies being asked to walk a ...

US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...

China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical ...

Would stricter insider trading regulations make financial markets fairer? China's 2017 sell-by-plan mandate was designed to ...

BEIJING - China's reform efforts to promote research and development on medical innovation and shorten the review and approval time for the launch of related drugs have provided innovation-driven ...

While China enforces strict laws against domestic drug trafficking, state-supported companies have openly shipped fentanyl to ...

The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector had reported that they had been able to import drugs to China over the past week with tariff ...

This guide compares nanomaterial regulations across the EU, U.S., Canada, China, Japan, and Australia, highlighting safety ...

As per the latest GTRI report, India could gain from US tariffs on China; however, exporters must comply with the US customs regulations.

Talks continue between the U.S. and China on tackling the fentanyl epidemic amid the bitter trade war between the world’s two ...